Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Conatus Pharmaceutic (CNAT)

5.01 -0.12 (-2.34%)

8/18/2017  4:00pm

Open:

5.06

Pre. Close:

5.13

High:

5.19

Low:

4.91

Volume:

378,572

Market Cap:

150.32M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

5.21 - 5.49

5.49 - 5.73

Low:

4.67 - 4.78

4.78 - 4.87

Close:

4.86 - 5.05

5.05 - 5.23

Technical analysis  (as of: 2017-08-18 4:37:07 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 6.91     One year: 7.71

Support:

Support1: 4.80    Support2: 3.99

Resistance:

Resistance1: 5.91    Resistance2: 6.60

Pivot:

5.23

Moving Averages:

MA(5): 5.09     MA(20): 5.41

MA(100): 5.98     MA(250): 4.31

MACD:

MACD(12,26): -0.22     Signal(12,26,9): -0.19

%K %D:

%K(14,3): 24.87     %D(3): 23.87

RSI:

RSI(14): 37.62

52-Week:

High: 9.40  Low: 1.45  Change(%): 159.6

Average Vol(K):

3-Month: 62149  10-Days 14079

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
CNAT has closed above bottom band by 16.7%. Bollinger Bands are 65.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to CNAT's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 20 Dec 2016 14:15:00 GMT
Conatus Pharmaceuticals Inc - A Deal Emerges With Novartis As The NASH Field ...

Mon, 15 May 2017 18:56:15 GMT
Revisiting Conatus Pharmaceuticals Due To Recent Pipeline Expansion Talks

Thu, 06 Jul 2017 20:03:45 GMT
Conatus Pharmaceuticals to Report Second Quarter 2017 Financial Results

Wed, 02 Aug 2017 20:03:45 GMT
Conatus Pharmaceuticals Reports Second Quarter 2017 Financial Results and ...

Fri, 07 Jul 2017 12:51:04 GMT
Why Conatus Pharma Wins With Newest Licensing Agreement

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

30.00

Shares Float (M)

25.30

% Held by Insiders

26.83

% Held by Institutions

34.40

Shares Short (K)

794

Shares Short Prior Month (K)

2800

Stock Financials

EPS

-1.090

EPS Est. Current Year

-0.450

EPS Est. Next Year

-0.170

EPS Est. Next Quarter

-0.140

Forward EPS

-0.090

Book Value (p.s.)

0.740

PEG Ratio

-0.19

Profit Margin

-140.57

Operating Margin

-141.34

Return on Assets (ttm)

-24.0

Return on Equity (ttm)

-80.6

Qtrly Rev. Growth

Gross Profit (p.s.)

0.027

Sales Per Share

EBITDA (p.s.)

-0.835

Qtrly Earnings Growth

Operating Cash Flow (M)

Levered Free Cash Flow (M)

FoxReading.com

Valuation

P/E

-4.60

P/E Growth Ratio

-0.02

P/BV

6.77

P/S

217826096.00

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.